Hua YU, PhD, is Professor of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California. She received both undergraduate and graduate degrees in Molecular Biology from Columbia University in New York City. Dr Yu is a pioneer in STAT3 signaling in cancer, and was the first to provide the direct link between oncogenesis and tumor immune evasion; first to identify STAT3’s role in tumor angiogenesis. Her work has uncovered many aspects of tumor-immune cell interactions. Recently, she has also developed a targeted siRNA delivery technology platform to silence desired genes in both normal and transformed myeloid cells and B cells. A summary of her work can be found in the following receent publications. Nature Reviews Cancer 2009, 9(11):798-809. Nature Biotechnology 2009, 27(10) 925-932. Cancer Cell 2009,15(4):283-93. Cancer Cell 2009, 15: 114-123. Nature Reviews Immunology 2007, 7:41-51.